Cancer Drugs Boom Spurred by FDA Moving at Lightning Speed
This article is for subscribers only.
More new drugs are getting the green light in the U.S. as drugmakers take advantage of a speedier metabolism at the Food and Drug Administration.
Through March 19, the FDA has approved 10 new drugs, on pace to match last year’s total of 41, which was an 18-year high.